Eli Lilly & Co Stock Analysis & Ratings
LLY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$220.20 - $330.85
Previous Close$324.71
Volume1.82M
Average Volume (3M)3.06M
Market CapN/A
Enterprise ValueN/A
P/E Ratio48.2
Beta0.54
Next EarningsAug 04, 2022
EPS Forecast$1.73
Next Dividend Ex-DateAug 12, 2022
Dividend Yield3.79 (1.13%)
1Y Price Target$325.38
Smart Score9
Eli Lilly & Co News
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LLY FAQ
What was Eli Lilly & Co’s price range in the past 12 months?
Eli Lilly & Co lowest stock price was $220.20 and its highest was $330.85 in the past 12 months.
What is Eli Lilly & Co’s market cap?
Currently, no data Available
What is Eli Lilly & Co’s price target?
The average price target for Eli Lilly & Co is $325.38. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $369.00 ,the lowest forecast is $260.00. The average price target represents 0.21% Increase from the current price of $324.71.
The highest analyst price target is $369.00 ,the lowest forecast is $260.00. The average price target represents 0.21% Increase from the current price of $324.71.
What do analysts say about Eli Lilly & Co?
Eli Lilly & Co’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
When is Eli Lilly & Co’s upcoming earnings report date?
Eli Lilly & Co’s upcoming earnings report date is Aug 04, 2022 which is in 32 days.
How were Eli Lilly & Co’s earnings last quarter?
Eli Lilly & Co released its earnings results on Apr 28, 2022. The company reported $2.62 earnings per share for the quarter, beating the consensus estimate of $2.292 by $0.328.
Is Eli Lilly & Co overvalued?
According to Wall Street analysts Eli Lilly & Co’s price is currently Undervalued.
Does Eli Lilly & Co pay dividends?
Eli Lilly & Co pays a Quarterly dividend of $0.98 which represents an annual dividend yield of 1.13%. Eli Lilly & Co’s last Quarterly dividend payment was on Sep 09, 2022. Eli Lilly & Co’s upcoming ex-dividend date is Aug 12, 2022
What is Eli Lilly & Co’s EPS estimate?
Eli Lilly & Co’s EPS estimate is $1.73.
How many shares outstanding does Eli Lilly & Co have?
Eli Lilly & Co has 950,159,550 shares outstanding.
What happened to Eli Lilly & Co’s price movement after its last earnings report?
Eli Lilly & Co reported an EPS of $2.62 in its last earnings report, beating expectations of $2.292. Following the earnings report the stock price went up 4.273%.
Which hedge fund is a major shareholder of Eli Lilly & Co?
Among the largest hedge funds holding Eli Lilly & Co’s share is PRIMECAP Management Co. It holds Eli Lilly & Co’s shares valued at 8B.
---
Eli Lilly & Co Stock Analysis
Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Price Target
$325.38
Moderate Buy▲(0.21% Upside)
Analyst Forecast
Moderate Buy
Average Price Target: $325.38
Blogger Sentiment
Bullish
LLY Sentiment 78% Sector Average 72%
Hedge Fund Holdings
▼ Decreased
By 147.8K Shares Last Quarter.
Insider Transactions
▼ Sold Shares
Worth $615.5M over the Last 3 Months
Retail Investors
Very Positive
Last 7 Days ▲ 1.3% Last 30 Days ▲ 5.8%
News Sentiment
Positive
Bullish 100% Bearish 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.46%
12-Months-Change
Fundamentals
Return on Equity
75.53%
Trailing 12-Months
Asset Growth
0.17%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Eli Lilly & Co
Founded in 1876, Eli Lilly & Co. is a leading healthcare company that manufactures and sells pharmaceutical products worldwide. The company is headquartered in Indianapolis, Indiana.
---
Company
Price & Change
Follow
Pfizer
―
Merck & Company
―
AstraZeneca
―
Novartis
―
GlaxoSmithKline
―
---